
Dermapharm Investor Relations Material
Latest events

Q1 2025
15 May, 2025

Q4 2024
28 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Dermapharm Holding SE
Access all reports
Dermapharm Holding SE is a Germany-based pharmaceutical company specializing in the development, production, and marketing of branded prescription and over-the-counter (OTC) medicines, dietary supplements, and medical devices. The company focuses on niche markets, offering a diverse portfolio of products across therapeutic areas such as dermatology, allergy, and pain management. Dermapharm also provides contract manufacturing services to third-party pharmaceutical companies. The company is headquartered in Grünwald, Germany, and its shares are listed on the Frankfurt Stock Exchange.
Latest articles
)
Nintendo: From Game Boy and Pokémon to Switch 2 and Mario Kart
Nintendo went from card maker to cultural icon, shaping modern entertainment through hardware innovation and world-famous characters.
19 Jun 2025
)
Ron Vachris: From Forklift Driver to CEO at Costco
Ron Vachris took over as Costco CEO in 2024, following a 40-year journey from warehouse floors to the top of one of retail's most admired companies.
18 Jun 2025
)
Luca de Meo: Succeeding Pinault as the New CEO of Kering
Luca de Meo's leap from auto to luxury marks a bold new chapter as he becomes the first non-Pinault CEO to lead the Kering empire.
16 Jun 2025
Ticker symbol
DMP
Country
🇩🇪 Germany